96 related articles for article (PubMed ID: 6411378)
1. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7'-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya.
Autrup H; Bradley KA; Shamsuddin AK; Wakhisi J; Wasunna A
Carcinogenesis; 1983 Sep; 4(9):1193-5. PubMed ID: 6411378
[TBL] [Abstract][Full Text] [Related]
2. Detection of 8,9-dihydro-(7'-guanyl)-9-hydroxyaflatoxin B1 in human urine.
Autrup H; Wakhisi J; Vahakangas K; Wasunna A; Harris CC
Environ Health Perspect; 1985 Oct; 62():105-8. PubMed ID: 3936705
[TBL] [Abstract][Full Text] [Related]
3. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
Bennett RA; Essigmann JM; Wogan GN
Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
[TBL] [Abstract][Full Text] [Related]
4. Detection of exposure to aflatoxin in an African population.
Autrup H; Wakhisi J
IARC Sci Publ; 1988; (89):63-6. PubMed ID: 3143673
[TBL] [Abstract][Full Text] [Related]
5. In vitro reactions of aflatoxin B1-adducted DNA.
Groopman JD; Croy RG; Wogan GN
Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5445-9. PubMed ID: 6795633
[TBL] [Abstract][Full Text] [Related]
6. Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine.
Zhu JQ; Zhang LS; Hu X; Xiao Y; Chen JS; Xu YC; Fremy J; Chu FS
Cancer Res; 1987 Apr; 47(7):1848-52. PubMed ID: 3102051
[TBL] [Abstract][Full Text] [Related]
7. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
Autrup H; Seremet T; Wakhisi J; Wasunna A
Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
[TBL] [Abstract][Full Text] [Related]
8. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
[TBL] [Abstract][Full Text] [Related]
9. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
Essigmann JM; Croy RG; Nadzan AM; Busby WF; Reinhold VN; Büchi G; Wogan GN
Proc Natl Acad Sci U S A; 1977 May; 74(5):1870-4. PubMed ID: 266709
[TBL] [Abstract][Full Text] [Related]
10. Wobble dC.dA pairing 5' to the cationic guanine N7 8,9-dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin B1 adduct: implications for nontargeted AFB1 mutagenesis.
Giri I; Stone MP
Biochemistry; 2003 Jun; 42(23):7023-34. PubMed ID: 12795597
[TBL] [Abstract][Full Text] [Related]
11. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon.
Autrup H; Essigmann JM; Croy RG; Trump BF; Wogan GN; Harris CC
Cancer Res; 1979 Mar; 39(3):694-8. PubMed ID: 427755
[TBL] [Abstract][Full Text] [Related]
13. Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry.
Egner PA; Groopman JD; Wang JS; Kensler TW; Friesen MD
Chem Res Toxicol; 2006 Sep; 19(9):1191-5. PubMed ID: 16978023
[TBL] [Abstract][Full Text] [Related]
14. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.
Smela ME; Hamm ML; Henderson PT; Harris CM; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6655-60. PubMed ID: 12011430
[TBL] [Abstract][Full Text] [Related]
15. Assessment of aflatoxin exposure using serum and urinary biomarkers in São Paulo, Brazil: A pilot study.
Jager AV; Tonin FG; Baptista GZ; Souto PC; Oliveira CA
Int J Hyg Environ Health; 2016 May; 219(3):294-300. PubMed ID: 26740158
[TBL] [Abstract][Full Text] [Related]
16. Associations of serum aflatoxin B1-lysine adduct level with socio-demographic factors and aflatoxins intake from nuts and related nut products in Malaysia.
Leong YH; Rosma A; Latiff AA; Izzah AN
Int J Hyg Environ Health; 2012 Apr; 215(3):368-72. PubMed ID: 22230243
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
[TBL] [Abstract][Full Text] [Related]
18. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
[No Abstract] [Full Text] [Related]
19. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
[TBL] [Abstract][Full Text] [Related]
20. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
